Cargando…

Identification of an aprotinin antiviral domain

Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments. Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity. One of the forme...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrini, Antonio, Thomas, Ursula, Franchini, Marco, Stöckli, Martina, Klauser, Stefan, Hunziker, Peter, von Fellenberg, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130179/
https://www.ncbi.nlm.nih.gov/pubmed/7514546
http://dx.doi.org/10.1016/0014-5793(94)00396-3
_version_ 1783516952147263488
author Pellegrini, Antonio
Thomas, Ursula
Franchini, Marco
Stöckli, Martina
Klauser, Stefan
Hunziker, Peter
von Fellenberg, Roland
author_facet Pellegrini, Antonio
Thomas, Ursula
Franchini, Marco
Stöckli, Martina
Klauser, Stefan
Hunziker, Peter
von Fellenberg, Roland
author_sort Pellegrini, Antonio
collection PubMed
description Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments. Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity. One of the former oligopeptides showed antiviral activity against human herpes simplex virus type 1 and bovine parainfluenza virus type 3. It consisted of the hexapeptide Y-F-Y-N-A-K corresponding to amino acids 21–26 of intact aprotinin. An identical synthetic peptide had the same antiviral spectrum as the natural hexapeptide, exhibited no antibacterial activity, and was also devoid of trypsin inhibiting activity. Intact aprotinin, in contrast, is ineffective against human herpes simplex virus 1 and bovine parainfluenza virus 3 but possesses antibacterial properties against several bacterial species [(1992) J. Appl. Bact. 72, 180–187].
format Online
Article
Text
id pubmed-7130179
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71301792020-04-08 Identification of an aprotinin antiviral domain Pellegrini, Antonio Thomas, Ursula Franchini, Marco Stöckli, Martina Klauser, Stefan Hunziker, Peter von Fellenberg, Roland FEBS Lett Article Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments. Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity. One of the former oligopeptides showed antiviral activity against human herpes simplex virus type 1 and bovine parainfluenza virus type 3. It consisted of the hexapeptide Y-F-Y-N-A-K corresponding to amino acids 21–26 of intact aprotinin. An identical synthetic peptide had the same antiviral spectrum as the natural hexapeptide, exhibited no antibacterial activity, and was also devoid of trypsin inhibiting activity. Intact aprotinin, in contrast, is ineffective against human herpes simplex virus 1 and bovine parainfluenza virus 3 but possesses antibacterial properties against several bacterial species [(1992) J. Appl. Bact. 72, 180–187]. Published by Elsevier B.V. 1994-05-16 2001-12-07 /pmc/articles/PMC7130179/ /pubmed/7514546 http://dx.doi.org/10.1016/0014-5793(94)00396-3 Text en Copyright © 1994 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pellegrini, Antonio
Thomas, Ursula
Franchini, Marco
Stöckli, Martina
Klauser, Stefan
Hunziker, Peter
von Fellenberg, Roland
Identification of an aprotinin antiviral domain
title Identification of an aprotinin antiviral domain
title_full Identification of an aprotinin antiviral domain
title_fullStr Identification of an aprotinin antiviral domain
title_full_unstemmed Identification of an aprotinin antiviral domain
title_short Identification of an aprotinin antiviral domain
title_sort identification of an aprotinin antiviral domain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130179/
https://www.ncbi.nlm.nih.gov/pubmed/7514546
http://dx.doi.org/10.1016/0014-5793(94)00396-3
work_keys_str_mv AT pellegriniantonio identificationofanaprotininantiviraldomain
AT thomasursula identificationofanaprotininantiviraldomain
AT franchinimarco identificationofanaprotininantiviraldomain
AT stocklimartina identificationofanaprotininantiviraldomain
AT klauserstefan identificationofanaprotininantiviraldomain
AT hunzikerpeter identificationofanaprotininantiviraldomain
AT vonfellenbergroland identificationofanaprotininantiviraldomain